
Paul Hemings
Paul is a Partner and Co-Founder of Nelson Advisors. He brings more than a decade of global M&A and capital raising expertise, and 10 years of entrepreneurial experience having founded and exited from 2 early-stage companies, most recently in metabolic HealthTech.
Prior to his early-stage ventures, Paul held investment and strategy roles at Invesco, and senior investment banking advisory roles at Credit Suisse where his transaction experience included over £50 Billion of M&A and £40 Billion of equity/financing.
Paul remains an active Board Advisor to a number of early-stage tech companies across the health/med tech, fintech and consumer sectors. Paul has an honours degree in Economics from Queen’s University (Canada) and an MBA from London Business School.
His extensive corporate finance experience includes $50+ Billion of Mergers & Acquisitions and $40+ Billion equity/financing transactions across US, UK, Ireland, Sweden, Denmark, Switzerland, Germany, Austria, Italy, Poland, Ukraine, Russia, Kazakhstan, Hong Kong, Singapore and Australia.
As Co-Founder of Neutrally, Paul focused on intercepting chronic lifestyle disease with data-led habit change around nutrition, exercise, sleep + mental well-being. His research led to the commercial application of the future of weight management, wellness & longevity.
-
16-Oct-2025Room 5Health Tech Deal Structuring